drugset / Trial / NCT00124124
Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine
RandomizedParallel-groupOpen-labelTreatment
Summary
In this study, a melanoma vaccine (5 melanoma peptides) is given with either Montanide or dendritic cells as adjuvants. This randomized trial will establish the safety of both vaccines and compare the 2 vaccine adjuvants in their efficacy to induce immune responses.
Timeline
- Start
- 2005-07
- Primary completion
- 2008-07
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dendritic cells | Cell therapy | 500000 cells | Other |
| Subject | Dendritic cells | Cell therapy | 3e+06 cells | Other |
| Subject | Montanide | Other / unclassified | — | Subcutaneous |
| Background | KLH | Unknown | 100 ug | Other |